Bextra and Vioxx Withdrawal Spawn Advertising Pause from Bri

Pharmaceutical giant Bristol Myers Squibb has announced that they will suspend direct-to-consumer advertising for their prescription drug products for a year. This comes in the wake of the well-publicized withdrawals of Merck